|
FY2025
12 months to Dec 26, 2025
|
FY2024
12 months to Dec 27, 2024
|
FY2023
12 months to Dec 29, 2023
|
FY2022
12 months to Dec 30, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Amortization of intangible assets | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest expense, net | |||||
| Other expense, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Net income per share basic (in usd per share) | |||||
| Net income per share diluted (in usd per share) | |||||
| Shares used to compute Net loss per share: | |||||
| Shares used to compute net income per share, basic (in shares) | |||||
| Shares used to compute net income per share, diluted (in shares) |
Loading...